Robson M - Search Results

1

BRCA mutations in women with ductal carcinoma in situ.

Smith KL, Adank M, Kauff N, Lafaro K, Boyd J, Lee JB, Hudis C, Offit K, Robson M. Smith KL, et al. Among authors: robson m. Clin Cancer Res. 2007 Jul 15;13(14):4306-10. doi: 10.1158/1078-0432.CCR-07-0146. Clin Cancer Res. 2007. PMID: 17634561

2

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J, Ellis N, Hensley M, Boyd J, Borgen P, Norton L, Offit K. Scheuer L, et al. Among authors: robson m. J Clin Oncol. 2002 Mar 1;20(5):1260-8. doi: 10.1200/JCO.2002.20.5.1260. J Clin Oncol. 2002. PMID: 11870168

3

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K. Satagopan JM, et al. Among authors: robson m. Clin Cancer Res. 2002 Dec;8(12):3776-81. Clin Cancer Res. 2002. PMID: 12473589

4

Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.

Offit K, Gilad S, Paglin S, Kolachana P, Roisman LC, Nafa K, Yeugelewitz V, Gonzales M, Robson M, McDermott D, Pierce HH, Kauff ND, Einat P, Jhanwar S, Satagopan JM, Oddoux C, Ellis N, Skaliter R, Yahalom J. Offit K, et al. Among authors: robson m. Clin Cancer Res. 2002 Dec;8(12):3813-9. Clin Cancer Res. 2002. PMID: 12473594

5

Hereditary ovarian cancer in Ashkenazi Jews.

Robles-Díaz L, Goldfrank DJ, Kauff ND, Robson M, Offit K. Robles-Díaz L, et al. Among authors: robson m. Fam Cancer. 2004;3(3-4):259-64. doi: 10.1007/s10689-004-9552-0. Fam Cancer. 2004. PMID: 15516850 Review.

6

Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series.

Robson M, Svahn T, McCormick B, Borgen P, Hudis CA, Norton L, Offit K. Robson M, et al. Cancer. 2005 Jan 1;103(1):44-51. doi: 10.1002/cncr.20728. Cancer. 2005. PMID: 15558796 Free article.

7

Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2.

Goldfrank D, Chuai S, Bernstein JL, Ramon Y Cajal T, Lee JB, Alonso MC, Diez O, Baiget M, Kauff ND, Offit K, Robson M. Goldfrank D, et al. Among authors: robson m. Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2311-3. doi: 10.1158/1055-9965.EPI-06-0176. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17119064

8

BRCA-associated breast cancer: absence of a characteristic immunophenotype.

Robson M, Rajan P, Rosen PP, Gilewski T, Hirschaut Y, Pressman P, Haas B, Norton L, Offit K. Robson M, et al. Cancer Res. 1998 May 1;58(9):1839-42. Cancer Res. 1998. PMID: 9581822

9

BRCA-associated breast cancer in young women.

Robson M, Gilewski T, Haas B, Levin D, Borgen P, Rajan P, Hirschaut Y, Pressman P, Rosen PP, Lesser ML, Norton L, Offit K. Robson M, et al. J Clin Oncol. 1998 May;16(5):1642-9. doi: 10.1200/JCO.1998.16.5.1642. J Clin Oncol. 1998. PMID: 9586873

10

Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.

Robson M, Levin D, Federici M, Satagopan J, Bogolminy F, Heerdt A, Borgen P, McCormick B, Hudis C, Norton L, Boyd J, Offit K. Robson M, et al. J Natl Cancer Inst. 1999 Dec 15;91(24):2112-7. doi: 10.1093/jnci/91.24.2112. J Natl Cancer Inst. 1999. PMID: 10601383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,561 results

Search Page

Filters